Procter & Gamble Health Share Price

P & G Health Ltd

CMP as on 20-May-22 15:56

₹ 4,366.35
22.60 0.52%

Open

₹ 4,343.85

Turnover (lac)

₹ 72

Prev. Close

₹ 4,343.75

Day's Vol (shares)

₹ 1,658

Day's Range (₹)

₹ 4,343.85
₹ 4,377.55

CMP as on20-May-22 15:28

₹ 4,371.85
21.8 0.5%

Open

₹ 4,358.45

Turnover (lac)

₹ 12

Prev. Close

₹ 4,350.05

Day's Vol (shares)

₹ 326

Day's Range

₹ 4,353.45
₹ 4,380.25

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 30-Mar-2022 - -
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2022 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday May 05 2022 inter alia to consider and approve the unaudited financial results for the quarter ended March 31 2022 Kindly take the same on record. Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2022 ,inter alia, to consider and approve We refer to our letter dated March 30, 2022, informing that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 5, 2022, to consider and approve Unaudited Financial Results for the quarter ended March 31, 2022. We would like to further inform you that the Board at the said meeting, would also consider declaration of interim dividend for the Financial Year 2021-22. The record date for payment of the Interim dividend, if declared at the Board meeting, will be Friday, May 13, 2022. Kindly take the same on record. (As Per BSE Announcement dated on 28.04.2022) We are pleased to inform you that at the meeting of the Board of Directors of the Company held today (commenced at 6:00 p.m. and ended at 7: 20 p.m.), the Unaudited Financial Results for the quarter ended March 31,2022 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended March 31, 2022; b. Press Release; and c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended March 31, 2022 furnished by Statutory Auditors of the Company Further, we are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended an Interim Dividend for the Financial Year 2021-22 of Rs. 41 per Equity Share (Face Value of Rs. 10/- each). The dividend shall be paid on or before May 31, 2022. (As Per BSE Announcement Dated on 05/05/2022)
Board Meeting - 17-Jan-2022 - -
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday February 9 2022 inter alia to consider and approve the unaudited financial results for the quarter ended December 31 2021. We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended December 31, 2021 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended December 31, 2021; b. Press Release; and c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended December 31, 2021 furnished by Statutory Auditors of the Company Kindly take the same on record and oblige. (As per BSE Announcement Dated on 09/02/2022)
Board Meeting - 08-Oct-2021 - -
Quarterly Results We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended September 30, 2021 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended September 30, 2021; b. Press Release; and c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended September 30, 2021 furnished by Statutory Auditors of the Company Kindly take the same on record and oblige. (As Per BSE Announcement dated on 09.11.2021)
Board Meeting - 16-Aug-2021 - -
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/08/2021 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday August 262021 inter alia to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30 2021 and to consider recommendation of dividend (if any). We inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended a final dividend of Rs. 130 per equity share, for the financial year ended June 30, 2021, which includes a one-time special dividend of Rs. 90 per equity share. Kindly take the same on record. (As Per BSE Announcement Dated on 26.08.2021) We inform you that the Board of Directors of the Company at its meeting held today inter alia have recommended a final dividend of Rs. 130 per equity share for the financial year ended June 30 2021 which includes a one-time special dividend of Rs. 90 per equity share. Kindly take the same on record. (As Per BSE Announcement Dated on 8/26/2021 7:28:10 AM) We inform you that the Board of Directors of the Company at its meeting held today inter alia have recommended a final dividend of Rs. 130 per equity share for the financial year ended June 30 2021 which includes a one-time special dividend of Rs. 90 per equity share. Kindly take the same on record. (As Per BSE Announcement Dated on 8/26/2021 7:28:10 AM)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity